<DOC>
	<DOC>NCT01124344</DOC>
	<brief_summary>The main purpose of this study is to determine whether multiple doses.of BMS-886949 are safe and tolerable</brief_summary>
	<brief_title>Safety and Pharmacology Study of BMS-866949</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<criteria>Panels 16: Healthy Male Subjects Panel 7: Females Ages 21 to 55, inclusive Body Mass Index (BMI) of 18 to 32 kg/mÂ², inclusive Healthy subjects as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations History of glaucoma or a confirmed intraocular pressure indicative of glaucoma at screening. (Normal IOP &lt;21 mmHg) History or family history of psychiatric disorder Current treatment with prescription medication Exposure to any investigational drug or placebo within 12 weeks of study drug administration</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>